Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00070447
Status:
COMPLETED
Last Update Posted:
2014-01-28
First Post:
2003-10-03
Brief Title:
Rituximab Prednisone Cyclophosphamide Doxorubicin Vincristine and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-06
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-03
First Submit QC Date:
October 6 2003
Study First Post Date:
2003-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-27
Last Update Post Date:
2014-01-28
Last Update Post Date Type:
ESTIMATED